Celgene (CELG) volatility elevated into acquiring Juno Therapeutics for approximately $87 per share in cash
Tweet
Share
E-mail
Get Alerts CELG Hot Sheet
Join SI Premium – FREE
Celgene (NASDAQ: CELG) January weekly call option implied volatility is at 46, February is at 33; compared to its 52-week range of 17 to 38 into acquiring Juno Therapeutics (JUNO) for approximately $87 per share in cash.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx, Advent-led consortium cleats 80% threshold to buy Inpost - Bloomberg
- Ginkgo Bioworks (DNA) 4K contracts of December 11 calls trade, share price up 15%
- SpaceX (SPCX) call put ratio 1 call to 1 put amid wide price movement
Create E-mail Alert Related Categories
Mergers and Acquisitions, Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
